Abstract
The present study evaluated the ability of tetrahydroaminoacridine (THA) to reverse the age-related increase in high voltage spindles (HVS). THA was injected either 15 or 90 min before EEG recordings were made. A THA dose of 3 mg/kg IP decreased the incidence of HVS, but was ineffective at doses of 0.03 and 1 mg/kg. The HVS suppressing effect of THA (3 mg/kg) declined during a 10-day treatment period. After 10 days chronic THA treatment, a challenge dose of 6 mg/kg of THA reinstated HVS suppressing effect of THA. Our results suggests that (1) THA reverses the age-related deficit of thalamo-cortical activation (2) tolerance develops to THA-induced HVS suppression (3) anti-cholinesterase activity may be important for the efficacy of THA in decreasing HVS because pilocarpine, a muscarinic agonist, also decreased HVS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Buzsaki G, Bickford RG, Armstrong DM, Chen K, Ruiz R, Thal L, Gage FGH (1988) Electrical activity in the neocortex of freely moving young and aged rats. Neuroscience 26:735–744
Dunnett SB, Whishaw EQ, Jones GH, Bunch ST (1987) Behavioural, biochemical and immunohistochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience 20:653–669
Flood JF, Cherkin A (1988) Effect of acute arecoline, tacrine and arecoline + tacrine post-training administration on retention in old mice. Neurobiol Aging 9:5–8
Haroutunian V, Kanof P, Tsyboyama GK, Campbell GA, Davis K, (1985) Animal models of Alzheimer's disease; behavior pharmacology, transplants. Can J Neurol Sci 13:385–393
Reinikainen KJ, Riekkinen P, Paljärvi L, Soininen H, Jolkkonen J, Laakso M (1988) Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem Res 13:135–146
Riekkinen P Jr, Sirviö J, Riekkinen P (1990a) Relationship between cortical ChAT content and EEG delta power. Neurosci Res 8:12–20
Riekkinen P Jr, Sirviö J, Riekkinen P (1990b) Effects of THA on medial septal lesion induced memory deficit. Pharmacol Biochem Behav 36:237–241
Riekkinen P Jr, Sirviö J, Miettinen R, Riekkinen P (1990c) Effects of quisqualic acid nucleus basalis lesion on neocortical EEG, passive avoidance and water-maze learning. Brain Res Bull 24:839–842
Scauf CL, Sattin A (1988) Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola. J Pharmacol Exp Ther 243:609–613
Sherman KA, Messamore E (1988) Blood cholinesterase inhibition as a guide to the efficacy of putative therapies for Alzheimer's dementia: comparison of tacrine and psysostigmine. In: Giacobini E, Becker R (eds) Current research in Alzheimer therapy: cholinesterase inhibitors. Taylor & Francis, New York
Sirviö J, Pitkänen A, Partanen J, Pääkkönen A, Riekkinen P (1989) Brain cholinergic enzymes and cortical EEG activity in young and old rats. Comp Biochem Physiol 94C:277–283
Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315:1241–1245
Tachiki KH, Spidell K, Samuels L, Ritzmann R, Steinberge A, Lloyd RL, Summers WK, Kling A (1988) Tacrine: Levels and effects on biogenic amines and their metabolites in specific areas of the rat brain. In: Giacobini E, Becker R (eds) Current research in Alzheimer therapy: cholinesterase inhibitors. Taylor & Francis, New York
Zornetzer SF (1985) Catecholamine involvement in age-related memory dysfunction. Ann NY Acad Sci 444:242–245
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riekkinen, P., Aaltonen, M. & Riekkinen, P. Tetrahydroaminoacridine inhibits high voltage spindle activity in aged rats after acute and chronic treatment. Psychopharmacology 103, 265–267 (1991). https://doi.org/10.1007/BF02244214
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02244214